A Clinical Trial to Evaluate Effect of IBB0979 in Patients With Advanced Malignant Tumors

Clinical trial NCT05991583 · RECRUITING

Trial details

NCT number: NCT05991583
Sponsor: SUNHO（China）BioPharmaceutical CO., Ltd.
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Advanced Malignant Tumors

Start date: 2023-07-03
Primary completion: 2025-11-30
Enrollment: 25

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.